INS and Insulin resistance: DAG, LCFA-CoA, and ceramides activates Protein Kinase-C (PKC), which causes serine phosphorylation of insulin receptor substrate (IRS) proteins, leading to the inhibition of insulin signaling and development of insulin resistance [6,7,8].